Osaic Holdings’s Oragenics OGEN Stock Holding History

Osaic Holdings’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	-$2	–	7644
2024 Q4	–	Hold	0	–	–	–	7379
2024 Q3	–	Sell	-1	Closed	-$28	–	7381
2024 Q2	$23	Sell	1 -3	-75%	-$136	﹤0.01%	7334
2024 Q1	$152	Buy	4 +3	+300%	+$296	﹤0.01%	6999
2023 Q4	$128	Hold	1	–	–	﹤0.01%	7091
2023 Q3	$67	Buy	+1	New	+$100	﹤0.01%	7260
2023 Q2	–	Hold	0	–	–	–	7382
2023 Q1	–	Hold	0	–	–	–	7428
2022 Q4	–	Hold	0	–	–	–	7361
2022 Q3	–	Sell	-1	Closed	-$584	–	7438
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7522
2022 Q1	$0	Buy	+1	New	+$733	﹤0.01%	7419
2021 Q4	–	Hold	0	–	–	–	7513
2021 Q3	–	Hold	0	–	–	–	7268
2021 Q2	–	Hold	0	–	–	–	7089
2021 Q1	–	Hold	0	–	–	–	6907
2020 Q4	–	Hold	0	–	–	–	6524
2020 Q3	–	Hold	0	–	–	–	6351
2020 Q2	–	Hold	0	–	–	–	6265

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GWM

GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mutual Advisors Omaha, Nebraska $5.31B AUM 25.12% 1-Year Est. Return

HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings's OGEN Position: Q1 2025 in Review

Osaic Holdings held its Oragenics (OGEN) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7644.

Osaic Holdings first reported a position in OGEN in Q1 2022 and has held it in 6 quarters since. The position peaked at $152 in Q1 2024. 17 funds tracked by Wall St. Rank hold OGEN as of Q1 2025.

Osaic Holdings held 0 shares of Oragenics worth $0 as of Q1 2025.
Osaic Holdings left its Oragenics share count unchanged in Q1 2025.
Oragenics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2025, its #7644 holding.
Osaic Holdings first reported a position in Oragenics in Q1 2022 and has held it in 6 quarters since.
Osaic Holdings's Oragenics position peaked at $152 in Q1 2024.
17 funds tracked by Wall St. Rank held Oragenics as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.